A detailed history of Exane Derivatives transactions in Exponent Inc stock. As of the latest transaction made, Exane Derivatives holds 2,257 shares of EXPO stock, worth $204,145. This represents 0.13% of its overall portfolio holdings.

Number of Shares
2,257
Previous 2,258 0.04%
Holding current value
$204,145
Previous $243,000 15.23%
% of portfolio
0.13%
Previous 0.08%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 12, 2022

SELL
$81.0 - $111.41 $81 - $111
-1 Reduced 0.04%
2,257 $206,000
Q1 2022

Apr 22, 2022

SELL
$84.33 - $116.96 $1,770 - $2,456
-21 Reduced 0.92%
2,258 $243,000
Q4 2021

Jan 28, 2022

BUY
$110.43 - $125.3 $20,319 - $23,055
184 Added 8.78%
2,279 $266,000
Q3 2021

Oct 26, 2021

SELL
$89.45 - $119.55 $9,839 - $13,150
-110 Reduced 4.99%
2,095 $237,000
Q2 2021

Jul 28, 2021

BUY
$86.06 - $102.31 $189,762 - $225,593
2,205 New
2,205 $196,000

Others Institutions Holding EXPO

About EXPONENT INC


  • Ticker EXPO
  • Exchange NASDAQ
  • Sector Industrials
  • Industry Consulting Services
  • Shares Outstandng 51,116,800
  • Market Cap $4.62B
  • Description
  • Exponent, Inc., together with its subsidiaries, operates as a science and engineering consulting company worldwide. It operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, building...
More about EXPO
Track This Portfolio

Track Exane Derivatives Portfolio

Follow Exane Derivatives and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exane Derivatives, based on Form 13F filings with the SEC.

News

Stay updated on Exane Derivatives with notifications on news.